Éric Bouffet

46.7k total citations · 3 hit papers
557 papers, 17.6k citations indexed

About

Éric Bouffet is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Éric Bouffet has authored 557 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 338 papers in Genetics, 219 papers in Neurology and 125 papers in Molecular Biology. Recurrent topics in Éric Bouffet's work include Glioma Diagnosis and Treatment (336 papers), Neuroblastoma Research and Treatments (168 papers) and Meningioma and schwannoma management (68 papers). Éric Bouffet is often cited by papers focused on Glioma Diagnosis and Treatment (336 papers), Neuroblastoma Research and Treatments (168 papers) and Meningioma and schwannoma management (68 papers). Éric Bouffet collaborates with scholars based in Canada, United States and France. Éric Bouffet's co-authors include Ute Bartels, Cynthia Hawkins, Donald Mabbott, Darren Hargrave, Uri Tabori, James T. Rutka, Michael D. Taylor, Annie Huang, Normand Laperrière and Brenda J. Spiegler and has published in prestigious journals such as Science, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Éric Bouffet

530 papers receiving 17.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medulloblastoma Comprises Four Distinct Molecular Variants

2010 886 citations Paul A. Northcott, Andrey Korshunov et al. Journal of Clinical Oncology profile →
Science and health for all children with cancer

2019 228 citations Éric Bouffet, Kathy Pritchard‐Jones et al. profile →
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

2023 125 citations Éric Bouffet, Jordan R. Hansford et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Éric Bouffet	10.3k	5.9k	5.0k	3.4k	2.6k	557	17.6k
Jonathan L. Finlay	9.0k 0.9×	5.0k 0.8×	4.2k 0.8×	3.2k 0.9×	2.0k 0.8×	326	13.6k
Larry E. Kun	10.2k 1.0×	5.8k 1.0×	4.7k 0.9×	6.0k 1.8×	2.7k 1.0×	373	20.5k
Thomas E. Merchant	9.1k 0.9×	3.8k 0.6×	2.7k 0.5×	6.5k 1.9×	2.6k 1.0×	444	17.9k
James M. Boyett	7.8k 0.8×	4.2k 0.7×	4.4k 0.9×	2.9k 0.8×	1.5k 0.6×	232	15.2k
Ian F. Pollack	7.9k 0.8×	4.6k 0.8×	5.1k 1.0×	2.2k 0.6×	2.0k 0.8×	381	16.6k
Amar Gajjar	13.3k 1.3×	5.6k 0.9×	8.9k 1.8×	4.7k 1.4×	2.2k 0.9×	429	23.5k
Roger J. Packer	15.0k 1.5×	10.1k 1.7×	8.1k 1.6×	5.6k 1.6×	4.3k 1.7×	465	27.6k
Richard Sposto	4.2k 0.4×	3.9k 0.7×	3.3k 0.7×	2.0k 0.6×	1.0k 0.4×	282	13.4k
Tarık Tihan	6.2k 0.6×	3.2k 0.5×	3.4k 0.7×	2.5k 0.7×	2.5k 1.0×	255	13.4k
Peter McL. Black	4.6k 0.4×	5.3k 0.9×	1.8k 0.4×	2.1k 0.6×	3.9k 1.5×	294	16.7k

Countries citing papers authored by Éric Bouffet

Since Specialization

Citations

This map shows the geographic impact of Éric Bouffet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Bouffet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Bouffet more than expected).

Fields of papers citing papers by Éric Bouffet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Bouffet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Bouffet. The network helps show where Éric Bouffet may publish in the future.

Co-authorship network of co-authors of Éric Bouffet

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Bouffet. A scholar is included among the top collaborators of Éric Bouffet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Bouffet. Éric Bouffet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasslocher‐Moreno, Alejandro Marcel, Vijay Ramaswamy, Anirban Das, et al.. (2025). Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma. Radiotherapy and Oncology. 207. 110865–110865.

Challinor, Julia, Kathryn Burns, Julia Downing, et al.. (2025). African Hospital‐Based Paediatric Palliative Oncology Care Independent of Economic Indicators: An International Society of Paediatric Oncology (SIOP) Global Mapping Programme Survey. Pediatric Blood & Cancer. 72(5). e31598–e31598.

Bouffet, Éric, et al.. (2024). Reporting on the Acceptance and Usability of a Virtual Reality Visual Rehabilitation Program in Pediatric Patients With Homonymous Hemianopia. 1(1). 147–162. 1 indexed citations

Geller, James I., Martine van Grotel, Marc Ansari, et al.. (2024). Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer. SHILAP Revista de lepidopterología. 5. 100211–100211.

Rajagopal, Revathi, et al.. (2023). Prognostic significance of molecular subgroups in survival outcome for children with medulloblastoma in Malaysia. Frontiers in Oncology. 13. 1278611–1278611. 2 indexed citations

Geoerger, Birgit, Lynley V. Marshall, Karsten Nysom, et al.. (2023). Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. European Journal of Cancer. 188. 8–19. 3 indexed citations

Ward, Richard, Hannah M. Jones, Frederick A. Boop, et al.. (2022). Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review. JCO Global Oncology. 8(8). e2200199–e2200199. 12 indexed citations

Laperrière, Normand, Vijay Ramaswamy, Éric Bouffet, et al.. (2021). Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma—a multi-institutional study. Neuro-Oncology Advances. 3(1). 4 indexed citations

Wagner, Matthias, Nicolin Hainc, Farzad Khalvati, et al.. (2021). Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation ofBRAF-Mutated andBRAF-Fused Tumors. American Journal of Neuroradiology. 42(4). 759–765. 36 indexed citations

10.

Renzi, Samuele, Orli Michaeli, S.P. Hector, et al.. (2020). Bevacizumab for NF2‐associated vestibular schwannomas of childhood and adolescence. Pediatric Blood & Cancer. 67(5). e28228–e28228. 21 indexed citations

11.

Sullivan, Michael, Éric Bouffet, Carlos Rodríguez‐Galindo, et al.. (2020). The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global. Pediatric Blood & Cancer. 67(7). e28409–e28409. 90 indexed citations

12.

Nobre, Liana, et al.. (2019). Effective and safe tumor inhibition using vinblastine in medulloblastoma. Pediatric Blood & Cancer. 66(6). e27694–e27694. 7 indexed citations

13.

Tsang, Derek S., Vijay Ramaswamy, Liana Nobre, et al.. (2019). Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience. Journal of Neuro-Oncology. 145(1). 107–114. 14 indexed citations

14.

Bouffet, Éric, Regina I. Jakacki, Stewart Goldman, et al.. (2012). Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma. Journal of Clinical Oncology. 30(12). 1358–1363. 143 indexed citations

15.

Geoerger, Birgit, Isabelle Aerts, María José Casanova, et al.. (2012). UPDATED RESULTS FROM A PHASE I STUDY OF LDE225, A SMOOTHENED ANTAGONIST, IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA OR OTHER SOLID TUMORS. UCL Discovery (University College London). 4 indexed citations

16.

Hawkins, Cynthia, Erin J. Walker, Nequesha S. Mohamed, et al.. (2011). BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma. Clinical Cancer Research. 17(14). 4790–4798. 176 indexed citations

17.

Northcott, Paul A., Andrey Korshunov, Hendrik Witt, et al.. (2010). Medulloblastoma Comprises Four Distinct Molecular Variants. Journal of Clinical Oncology. 29(11). 1408–1414. 886 indexed citations breakdown →

18.

Huang, Annie, Cynthia S.W. Ho, Romina Ponzielli, et al.. (2005). Identification of a Novel c-Myc Protein Interactor, JPO2, with Transforming Activity in Medulloblastoma Cells. Cancer Research. 65(13). 5607–5619. 67 indexed citations

19.

Baranzelli, M.C., Catherine Patte, Éric Bouffet, et al.. (1997). Nonmetastatic intracranial germinoma. Cancer. 80(9). 1792–1797. 80 indexed citations

20.

Baranzelli, M.C., Catherine Patte, Éric Bouffet, et al.. (1997). Nonmetastatic intracranial germinoma. Cancer. 80(9). 1792–1797. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact